DRKS00025088尚未招募不适用
Surgical treatment for oligoprogression in metastasized renal cell carcinoma after medical treatment
niversitätsklinikum Freiburg Klinik für Thoraxchirurgie0 个研究点目标入组 20 人开始时间: 2022年1月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with oligoprogressive metastatic renal cell carcinoma after drug therapy
- •- Surgical resection of one or more thoracic metastases at the Clinic for Thoracic Surgery, Freiburg, Germany
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANColigometastatic pancreatic cancerCTIS2023-503558-10-00niversitaetsmedizin Goettingen425
招募中
1 期
Evaluation of the impact of metastasis-directed therapy in patients with castration-refractory prostate cancer and a maximum of 5 progressive lesions.CTIS2022-502254-13-00Z Leuven246
招募中
不适用
ocal Ablative therapy for Oligometastases NSCLC - An Ambispective Observational Cohort StudyCTRI/2022/05/042654Anil Tibdewal
尚未招募
2 期
Treatment of limited Oligo Metastatic disease in Esophageal and Stomach carcinoma; TOMES trialstomach and esophagus cancerupperGi cancer10017990NL-OMON52125Antoni van Leeuwenhoek Ziekenhuis73
进行中（未招募）
1 期
Metastasis-directed therapy, whether or not in combination with hormone therapy, in patients with prostate cancer recurrence after initial treatment and a maximum of 5 metastasen.EUCTR2022-000066-18-BEniversitaire Ziekenhuizen Leuven873